Saturday, January 28, 2017

It's time to finally fix this

In 2010, the Society for Healthcare Epidemiology (SHEA) published a position paper that stated that annual influenza vaccination of healthcare workers should be a condition of employment on the basis of four studies performed in nursing homes. In other words, SHEA advised hospitals to fire HCWs who refused to get a flu shot. Other professional societies jumped on this insane bandwagon, and CMS made vaccine compliance rates publicly reportable and a metric in their hospital Star Rating program.

From the beginning, I have argued on this blog that SHEA's position was misguided for a number of reasons that I won't rehash in this post (see here, here, and here). Moreover, the Cochrane group evaluated the same four papers on which SHEA based its recommendation and determined there was no conclusive evidence that vaccinating HCWs was effective in reducing influenza in patients. But SHEA didn't back down. Another systematic review by another group came to the same conclusion. But SHEA didn't back down. CDC significantly downgraded the effectiveness of influenza vaccination to worse than placebo in some years. But SHEA didn't back down. And there's even a lack of evidence that influenza vaccine of healthcare workers reduces influenza in healthcare workers.

Now comes a 21-page paper (free full text here) in PLoS One by a group of Canadian epidemiologists that decimates those four nursing home studies. And all I can say is: SHEA better back down.

According to these investigators, all four studies violate the principle of dilution by reporting greater percentage reductions with less specific outcomes (i.e., the studies report percentage reductions in all-cause mortality > influenza-like illness (ILI) > laboratory-confirmed influenza). The principle of dilution requires that vaccine efficacy must be lower when non-targeted events (non-flu illnesses) are included in the study outcome than when only the target (confirmed influenza) contributes. The authors give the simple analogy of using an item-specific coupon at the grocery store--the percentage reduction in price on that item will always be much greater than the percentage reduction on your entire purchase that includes multiple other items. It's an irrefutable law of mathematics.

They also note several sources of bias. Depending on the study, there were differences in mortality between the control and intervention groups accrued before influenza arrived in the community, and there were issues with the definition of ILI. Estimates of numbers need to vaccinate were so flawed (off by as much as 4,000-fold) that if extrapolated to all healthcare workers in the US, more deaths would be averted than occurred in the 1918 influenza pandemic.

Here's the bottom line per the authors: Each of the four cluster RCTs used to champion compulsory HCW influenza vaccination policies reports benefits that are mathematically impossible under any reasonable hypothesis of indirect vaccine effect. It's hard to imagine a stronger conclusion.

If you don't read the entire paper, please read the discussion. Here's the concluding paragraph:
Through this detailed critique and quantification of the evidence we conclude that policies of enforced influenza vaccination of HCWs to reduce patient risk lack a sound empirical basis. In that context, an intuitive sense that there may be some evidence in support of some patient benefit is insufficient scientific basis to ethically override individual HCW rights. While HCWs have an ethical and professional duty not to place their patients at increased risk, so also have advocates for compulsory vaccination a duty to ensure that the evidence they cite is valid and reliable, particularly in the absence of good scientific estimates of patient impact. The diversion of resources from more evidence-based efforts and other important but less tangible costs related to loss of trust and credibility also need to be considered, including the implications for other immunization programs and workplace policies. Although current data are inadequate to support enforced HCW influenza vaccination, they do not refute approaches to support voluntary vaccination or other more broadly protective practices such as staying home or masking when acutely ill.

And if that's not enough, there's a commentary in the same journal, responding to the Canadian study written by the lead author of one of the nursing home studies. He defends his study, but importantly he states that the findings should not be extrapolated beyond the nursing home setting.

As I see it, unless SHEA cites alternative facts, it has three choices: change its position to recommending (not mandating) annual influenza vaccine for healthcare workers, articulate a damn good reason to support its current policy despite the evidence (hard to imagine what that would be), or simply retire the guideline (as it has quietly done for the 2003 highly controversial MRSA/VRE search and destroy recommendation). Given the assault on science that we are likely to see over the next four years in the US, SHEA must lead by ensuring that all of its recommendations are solidly based in evidence and that expectations for compliance with interventions correlate with the strength of the evidence. Just as we must defend vaccines from false claims of adverse effects, we must also truthfully acknowledge their limitations and shape our policy on science not opinion.

Thursday, January 26, 2017

Playing Nice: Infection Control and Clinical Microbiology in the Pay-For-Performance Era

As it's probably clear, it's been a great honor for me to work (and blog) with Dan and Mike over the past 8! years. One of the things that stands out when talking shop is their ability to see both sides of an argument even while pushing for the changes they support. Many times, their ability to see both sides clearly is possible because they've lived both sides - Mike has been an ID chief and hospital epidemiologist and is now our CQO and Dan is an ID chief, hospital epidemiologist and clinical microbiologist. You know, if I was a fellow or faculty member looking for a hospital epidemiologist position with great mentorship and support, I would move to Iowa...but I digress.

One specific area where understanding competing goals is critically important is the interplay between the increasing sensitivity and precision of microbiologic tests and the growing pressure to reduce HAI. As you can imagine, with 3% of CMS payments potentially at risk, anything that could impact HAI rates in a negative fashion is bound to be a flashpoint for hospital administrators. With that in mind, I point you to Dan's excellent commentary just published in JCM that examines the implications of advances in microbiological testing on HAI rates and provides specific suggestions for how hospital epi programs and clinical microbiology labs can work together to respond to these changes.

Initially, Dan provides three scenarios where changes in the micro lab could directly impact HAI rates (1) The effect of MALDI-TOF on CLABSI rates (2) The shift from EIA to nucleic-acid amplification tests (NAAT) for C. difficile detection and (3) Pressure to block urine culture ordering to reduce CAUTI. After delving into the current CMS reimbursement landscape, the unintended consequences of improvements in diagnostic testing and the use/misuse of surveillance definitions, he provides six valuable recommendations that clinical microbiology labs (CML) and infection prevention programs (IPP) should consider:

(1) CML leadership should select diagnostic approaches with the goal of improving individual patient outcomes

(2) Hospital and IPP leadership should not pressure the CML to alter diagnostic practices based on the need to demonstrate lower HAI rates for pay-for-performance measures. 

(3) Public health authorities (CDC/NHSN) must be proactive in adjusting HAI metrics to changing CML technology

For recommendations 4-6, you're gonna have to read his commentary. But a hint at #6 -  CML and IPP leadership need to collaborate and advocate for their needs, because, unlike at Iowa, both sides aren't always present in the mind of a single person.

Wednesday, January 25, 2017

Beating Back the Norovirus Devil

Well, many of us have sick feelings in our stomachs these days. It's norovirus season and the media is filled with the usual scary reports - "hard to get rid of" and "schools closing" - that generally provide non-specific information about how to prevent transmission in your home. The CDC does have useful information online and in graphic form (below). So, with homage to Maryn McKenna's excellent book about CDC's EIS, I offer my tips for beating norovirus in your home.

A bit of background on why I've put forth these recommendations: We've had three episodes of likely norovirus cases in our home since my initial norovirus post in 2013 and zero cases of transmission. Below is my 2017 case report with steps we took to prevent transmission.

Approximately 3 weeks ago, we had a group of five 10 yo kids at our house for a party. At some point, one of the kids started feeling sick and spit up a bit in our trash can and then while trying to get  to the bathroom vomited in our family room and near our front door before finally making it to a toilet. Thus, we had 3+ areas to decontaminate and 7 at-risk people we needed to protect. We immediately sent the other kids to the lower level, donned gloves and began the clean-up procedures.

1) We made sure that the sick child stayed in or near the bathroom and also made sure he closed the lid prior to flushing the toilet and poured a cup of bleach into the toilet before we flushed the toilet again. Once the child was picked up by their parent, we put the bathroom off limits.

2) We quickly blotted up the emesis in the living room and front hall with towels, being careful to not spray the virus. We then washed all of the towels twice in the hottest water setting and dried them until practically burnt (humor).

3) We removed all glasses, plates, silverware, xbox controllers and other things the child might have touched from circulation. The things we could wash in the dishwasher were washed 3 times and we used the drying cycle (which we usually don't use).

4) We used these bleach wipes (Clorox 35309 Healthcare Bleach Germicidal Wipe), which have activity vs norovirus, twice on each hard surface (bathroom, floor, XBox controller) to make sure we achieved adequate contact time.

5) For soft surfaces, that couldn't be laundered, we used (Clorox Healthcare Hydrogen Peroxide Spray) after first testing that it was color safe on our carpet.

6) And we enforced strict hand hygiene in the house for the next few days, using only soap and water.

Hope this helps - be careful out there.

Note: I have no financial relationship with amazon or clorox - that's just where I purchased the cleaning supplies and Ms. McKenna's book.






Sunday, January 22, 2017

M. chimaera update: SHEA webinar


Tomorrow (Monday, January 23 at 1 pm Eastern Time), Mike and I will be presenting an update on the global outbreak of heater-cooler device associated Mycobacterium chimaera. You can sign up for this SHEA webinar here (sorry for the late notice!). A CDC representative will join us for the Q&A.  Once it is done we'll either post a link to the webinar or make the slides available on the blog.

We hope you can join us!

UPDATE: here is the link to listen to the webinar

Friday, January 13, 2017

Pan-resistant NDM-containing K. pneumoniae lacking MCR-1

Hopefully, you've started your long weekend or begun planning your MLK-Jr Day of Service. But just in case, I wanted to let you know about a new case report in MMWR while simultaneously raising the MMWR Altmetric Score. Seriously, how can such a case only have one blog mention in 24 hours - Jon Otter must be just getting back from holiday.

CDC has reported a case of NDM-containing CRE K. pneumoniae isolated from a wound specimen of a woman in her 70s who had returned to the US after a log visit to India. She also reported prior visits with multiple hospitalizations in India. The isolate was resistant to the 26 antibiotics tested, including all aminoglycosides and polymyxins (despite being MCR-1 negative), while it was intermediately resistant to tigecycline. The fosfomycin MIC was 16 μg/mL. Unfortunately, the patient developed sepsis and died. Fortunately, the patient had been isolated and screening revealed no evidence of transmission.

CDC offered three take home points: (1) Most CRE remains susceptible to at least one aminoglycoside or tigecycline (2) When patients with this highly resistant organisms are identified, they should be placed under contact precautions* and (3) Facilities should obtain travel histories and consider screening for CRE if patients are from high-risk areas.


*Note: nice to see that somebody still loves contact precautions.

Love song to America?

This week I attended the 2017 ECCMID planning meeting in Rome. It's going to be a great meeting if the ~5000 abstracts we reviewed and slotted are any indication. I hope you're able to make it to Vienna this April. Of course, when not debating where to slot an abstract - podium, poster, mini-oral e-poster or e-poster, many of my European colleagues asked me about the state of affairs in the US and the world. I didn't have much to say since I've heretofore lived my life by two simple rules: "never get involved in a land war in Asia" and "never go in against a Sicilian when death is on the line." I simply don't have much opinion on amassing troops in Poland other than it didn't end well in the 1930s. So, most of the conversations went like this:

ECCMID colleague: "wtf?"

Me: "wtf."

ECCMID colleague: "WTF?"

Me: "WTF!"

On my taxi ride to Fiumicino Airport, Lady Gaga's "Million Reasons" was playing on the radio and it seemed to sum up how I feel about the current situation in the US. The song was released on November 9th...I wonder. And if you say something that you might even mean - It's hard to even fathom which parts I should believe... With all that's going on, many are looking for one good reason to stay

Wednesday, January 4, 2017

Recognizing the Value of Infection Control in Addressing the AMR Crisis

One of the challenges that all infection control and QI programs face is obtaining the necessary funding to complete all their required activities such as surveillance, reporting and prevention. Anthony Harris from the University of Maryland spent a great deal of time (e.g. SHEA White Paper on Necessary Infrastructure) as SHEA President pushing for increased resources for hospital epi activities. In a recent BMJ Quality and Safety editorial, Anthony offered suggestions for advancing the recognition and resources for infection control and QI activities, including societies (i.e. SHEA, APIC, ESCMID) partnering with governments to create comprehensive recommendations for infection control programs and funding.

Specifically, he recommends:

(a) guidelines by major organisations outlining the optimal reimbursement and full time employee (FTE) of hospital epidemiologists and infection preventionists for healthcare facilities in various settings. Currently, agencies such as CMS list certain conditions of participation for institutions relative to infection control and soon to be antibiotic stewardship; however, details of these requirements are vague and should be expanded

(b) as reimbursement moves away from fee per service and more towards quality outcomes driving reimbursement and penalties, we need more effective and novel methods of directing resources for day-to-day infection prevention. For example, an infection prevention fee could be imposed on all procedures that require significant infection prevention resources such as surgery or central line insertion and maintenance

(c) funding for state health departments to assist individual hospitals in establishing effective infection prevention programmes

(d) novel reimbursement models such as a fixed fee per surveillance culture reviewed, a fee for each chart reviewed to assess the appropriateness of antibiotic selection or an hourly fee for performing outbreak investigation may be warranted

(e) certification requirements for hospital epidemiology and QI experts that will help recruit and establish more experts to the field.

The full editorial (free full text access) is well worth reading. (COI alert: I'm a co-author)

OSHA! OSHA! OSHA!

  In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...